logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On September 17, STANCHART (02888) spent 733.73 million to repurchase 518,600 shares.

date
18/09/2025
avatar
GMT Eight
Standard Chartered Group (02888) announced that the company invested 7.3373 million on September 17, 2025...
STANCHART (02888) announced that it has repurchased 518,600 shares for 7.3373 million on September 17, 2025.
Related Articles
HK Stock
TIME WATCH (02033) issued a profit warning, anticipating an annual loss of HK$17 million for the company's shareholders compared to a profit.
HK Stock
Yu Cheng Kejin (00279) completes the placement of approximately 191 million shares.
US Stock
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) jumped in pre-market trading, Ozempic has better cardiovascular protective effects than traditional drugs like Lantus.
TIME WATCH (02033) issued a profit warning, anticipating an annual loss of HK$17 million for the company's shareholders compared to a profit.
HK Stock
Yu Cheng Kejin (00279) completes the placement of approximately 191 million shares.
HK Stock
Novo Nordisk A/S Sponsored ADR Class B (NVO.US) jumped in pre-market trading, Ozempic has better cardiovascular protective effects than traditional drugs like Lantus.
US Stock
RECOMMEND
SAFE Enhances Convenience of Cross-Border Investment and Financing
SAFE Enhances Convenience of Cross-Border Investment and Financing
icon
16/09/2025
U.S. Moves to Expand Strategic Uranium Reserves as Nuclear Sector Stocks Rally
U.S. Moves to Expand Strategic Uranium Reserves as Nuclear Sector Stocks Rally
icon
16/09/2025
From Falling Orders to Surging Fertilizer Costs, U.S. Farmers Confront a “Trade and Fiscal Cliff”
From Falling Orders to Surging Fertilizer Costs, U.S. Farmers Confront a “Trade and Fiscal Cliff”
icon
16/09/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.